Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Results of Annual General Meeting

29th Oct 2021 17:04

RNS Number : 7941Q

Sensyne Health PLC

29 October 2021

Sensyne Health plc('Sensyne' of the 'Company')

Results of Annual General Meeting

Oxford, UK, 29 October 2021: Sensyne Health plc (LSE: SENS), the ethical clinical AI company, is pleased to announce that at the Annual General Meeting ('AGM') held earlier today all resolutions were duly passed. The results of the votes received in advance and at the meeting are summarised below while the full text of the resolutions considered at the AGM are available on Sensyne's website (www.sensynehealth.com).

Results of the vote

Res No.	Votes For	%	Votes Against	%	Votes Total	% of ISC	Votes Withheld*
1	109,388,637	100.00%	0	0.00%	109,388,637	66.38%	0
2	101,205,237	92.52%	8,183,436	7.48%	109,388,637	66.38%	0
3	109,350,084	100.00%	0	0.00%	109,350,084	66.35%	38,589
4	109,384,673	99.99%	4,000	0.01%	109,388,673	66.38%	0
5	109,350,084	99.96%	38,589	0.04%	109,388,673	66.38%	0
6	109,350,084	100.00%	0	0.00%	109,350,084	66.35%	38,589
7	101,723,704	92.99%	7,664,969	7.01%	109,388,673	66.38%	0
8	109,350,084	100.00%	0	0.00%	109,350,084	66.35%	38,589
9	109,350,084	100.00%	0	0.00%	109,350,084	66.35%	38,589
10	109,350,084	100.00%	0	0.00%	109,350,084	66.35%	38,589
11	109,388,673	100.00%	0	0.00%	109,388,673	66.38%	0
12	109,388,301	99.99%	372	0.01%	109,388,673	66.38%	0
13	109,388,173	99.99%	500	0.01%	109,388,673	66.38%	0
14	109,348,520	99.96%	39,781	0.04%	109,388,301	66.38%	372
15	109,345,020	99.96%	43,281	0.04%	109,388,301	66.38%	372
16	109,345,020	99.96%	43,653	0.04%	109,388,673	66.38%	0
17	109,345,712	99.96%	42,961	0.04%	109,388,673	66.38%	0

* A vote withheld is not a vote in law and means the percentage of votes cast for and against excludes withheld votes.

-ENDS-

For more information please contact:

Sensyne Health
Lord (Paul) Drayson PhD FREng, Chief Executive Officer Dr Richard Pye, Chief Financial Officer	+44 (0) 330 058 1845
Peel Hunt LLP (Nominated Adviser and Joint Broker)
Dr Christopher Golden James Steel	+ 44 (0) 20 7418 8900
Liberum (Joint Broker)
Bidhi Bhoma Euan Brown	+ 44 (0) 20 3100 2000
Consilium Strategic Communications
Mary-Jane Elliott Jessica Hodgson [email protected]	+44 (0) 7780600290
SternIR
Julie Seidel [email protected]	+1 (212) 362-1200

About Sensyne Health

Sensyne Health plc is a clinical AI company that works in partnership with global healthcare organisations to improve patient care and accelerate the discovery and development of new medicines. Sensyne Health is listed on the AIM Market of the London Stock Exchange (SENS.L).

For more information, please visit: www.sensynehealth.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGUKRNRAUURUAA

Related Shares:

FTSE 100 Latest

Value8,809.74

Change53.53